Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

Details for Australian Patent Application No. 2007214766 (hide)

Owner Bayer HealthCare AG

Inventors Perzborn, Elisabeth; Keldenich, Joerg; Lerchen, Hans-Georg; Schlemmer, Karl-Heinz; Krenz, Ursula

Agent Davies Collison Cave

Pub. Number AU-A-2007214766

PCT Pub. Number WO2007/093328

Priority 10 2006 007 146.8 16.02.06 DE

Filing date 6 February 2007

Wipo publication date 23 August 2007

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/093328 Priority application(s): WO2007/093328

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007214777-Anti-reflective coated glas plate

2007214748-Dry powder inhaler device